Work productivity, associated risk factors and costs on presenteeism and absenteeism in Chinese patients with young‐onset type‐2 diabetes in Hong Kong
Authors' conclusion
This study is the first to quantify productivity costs in Chinese patients with YOD, highlighting the need for work place policies, intensive treatment and management strategies to enhance support for individuals with YOD.
Study context
- Population
- Chinese patients with YOD (T2D diagnosed before age 40 years), recruited June 2023–April 2024 in the Precision Medicine to redefine Insulin Secretion and Monogenic diabetes Trial, Hong Kong; 444 employed603 completed
- Participants
- 639 patients
- Outcome
- Presenteeism and absenteeism (WHO Health and Performance Questionnaire)
Main finding
As reported in the abstract
Mean presenteeism score
7.34/10
Experiencing productivity loss
93.9%
Mean sick days
0.48
Observational data: associations, not effects.
Further findings
Factors associated with productivity
- Increased productivity associated with females, child care, flexible work schedules and higher salary
- Reduced productivity related to albuminuria, use of lipid-lowering medications and more sick leaves
Projected territory-wide productivity losses (≈38 700 patients with YOD in Hong Kong) · annually
- Total
- US$444 million
- Presenteeism
- US$419 million
- Absenteeism
- US$25 million
Original publication
Work productivity, associated risk factors and costs on presenteeism and absenteeism in Chinese patients with young‐onset type‐2 diabetes in Hong Kong. Diabetes Obes Metab. Published 16 December 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →